13F filer · CIK 315066 ↗
Fidelity Investments
You are looking at Q4 2017. See the latest, Q2 2026 →
Reported value
$853.06B
+3.1% on the quarter before
Positions
2,646
217 new · 161 sold out
Top 10
17.8%
of the value
Est. gain
+$44.80B
on stocks held all quarter
Est. return
+5.9%
on those stocks since Q3 2017
Positions as of Dec 31, 2017, from Fidelity Investments's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 29% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2017. Striped tiles are options.
Largest buys
Since Q3 2017, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Ishares Tr~$1.35BAdded · 0.0% → 0.2%+5,018,130 shares
- Wal-Mart Stores Inc~$1.27BAdded · 0.2% → 0.4%+12,820,467 shares
- Dowdupont Inc~$1.13BAdded · 0.5% → 0.6%+15,920,696 shares
- Microsoft~$1.04BAdded · 1.6% → 1.9%+12,175,412 shares
- Schwab Charles Corp New~$889.0MAdded · 0.2% → 0.3%+17,305,691 shares
- Bank Amer Corp~$840.4MAdded · 1.0% → 1.2%+28,468,857 shares
- Becton Dickinson & Co~$665.1MAdded · 0.2% → 0.3%+3,106,965 shares
- Citrix Sys Inc~$650.6MAdded · 0.1% → 0.2%+7,393,051 shares
- Altria Group Inc~$649.3MAdded · 0.1% → 0.2%+9,092,957 shares
- Nektar Therapeutics~$640.0MAdded · 0.0% → 0.1%+10,717,509 shares
Largest sells
Since Q3 2017, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Apple~$4.02BCut · 2.7% → 2.4%−23,765,684 shares
- Medtronic Plc~$1.70BCut · 0.3% → 0.1%−20,998,557 shares
- Meta~$1.39BCut · 2.7% → 2.5%−7,858,340 shares
- Priceline Grp Inc~$1.38BCut · 0.4% → 0.3%−795,212 shares
- Amgen Inc~$1.24BCut · 1.3% → 1.1%−7,154,234 shares
- Charter Communications Inc N~$892.8MCut · 0.3% → 0.1%−2,657,560 shares
- Tesla~$878.2MCut · 0.8% → 0.6%−2,820,628 shares
- Alphabet~$857.4MCut · 2.1% → 2.1%−813,958 shares
- Delphi Automotive Plc~$771.6MSold out · 0.1% → 0.0%−7,841,609 shares
- Alphabet~$769.6MCut · 1.6% → 1.6%−735,472 shares
Holdings
As of Dec 31, 2017. Changes are in shares against Sep 30, 2017, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MetaCL A · shares −6.1% · price +3.3% | 2.5% | $21.46B | +$679.9M | ||||||||
| AppleCOM · shares −16% · price +9.8% | 2.4% | $20.60B | +$1.84B | ||||||||
| AmazonCOM · shares −2.9% · price +21.6% | 2.4% | $20.46B | +$3.64B | ||||||||
| AlphabetCAP STK CL A · shares −4.7% · price +8.2% | 2.1% | $17.54B | +$1.33B | ||||||||
| MicrosoftCOM · shares +6.9% · price +14.8% | 1.9% | $16.09B | +$1.94B | ||||||||
| AlphabetCAP STK CL C · shares −5.5% · price +9.1% | 1.6% | $13.24B | +$1.10B | ||||||||
| Unitedhealth Group IncCOM · shares −0.5% · price +12.6% | 1.5% | $12.55B | +$1.40B | ||||||||
| Bank Amer CorpCOM · shares +8.8% · price +16.5% | 1.2% | $10.43B | +$1.36B | ||||||||
| Jpmorgan Chase & CoCOM · shares −2.1% · price +12.0% | 1.1% | $9.75B | +$1.04B | ||||||||
| Visa Inc.COM CL A · shares −2.1% · price +8.3% | 1.1% | $9.64B | +$741.9M | ||||||||
| NvidiaCOM · shares −6.2% · price +8.2% | 1.1% | $9.32B | +$709.2M | ||||||||
| Amgen IncCOM · shares −12% · price −6.7% | 1.1% | $9.02B | −$651.1M | ||||||||
| Berkshire Hathaway Inc DelCL A · shares −0.1% · price +8.3% | 1.0% | $8.69B | +$667.9M | ||||||||
| SalesforceCOM · shares −0.8% · price +9.4% | 1.0% | $8.56B | +$738.0M | ||||||||
| Wells Fargo Co NewCOM · shares +1.1% · price +10.0% | 0.93% | $7.96B | +$716.8M | ||||||||
| Citigroup IncCOM NEW · shares −2.5% · price +2.3% | 0.92% | $7.87B | +$176.5M | ||||||||
| AdobeCOM · shares −1.4% · price +17.5% | 0.73% | $6.24B | +$928.1M | ||||||||
| Activision Blizzard IncCOM · shares −2.5% · price −1.8% | 0.72% | $6.13B | −$115.2M | ||||||||
| PayPalCOM · shares −4.3% · price +15.0% | 0.72% | $6.10B | +$794.9M | ||||||||
| Home Depot IncCOM · shares −2.0% · price +15.9% | 0.66% | $5.66B | +$774.9M | ||||||||
| MastercardCL A · shares −3.5% · price +7.2% | 0.66% | $5.64B | +$378.3M | ||||||||
| Dowdupont IncCOM · shares +28% · price +2.9% | 0.62% | $5.25B | +$115.0M | ||||||||
| TeslaCOM · shares −14% · price −8.7% | 0.61% | $5.20B | −$496.8M | ||||||||
| AlibabaSPONSORED ADS · shares +6.5% · price −0.2% | 0.58% | $4.91B | −$7.5M | ||||||||
| NetflixCOM · shares +2.9% · price +5.9% | 0.56% | $4.76B | +$255.9M | ||||||||
| Total · 2,646 positions | 100% | $853.06B | +$44.80B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2017 to Q4 2017: 2,369 stocks held throughout, up $44.80B (+5.9%).
- Amazon+$3.64B+22%
- Microsoft+$1.94B+15%
- Apple+$1.84B+10%
- Unitedhealth Group Inc+$1.40B+13%
- Bank Amer Corp+$1.36B+16%
- Tesla−$496.8M−9%
- Celgene Corp−$518.6M−28%
- General Electric Co−$572.7M−28%
- Amgen Inc−$651.1M−7%
- Boston Scientific Corp−$689.9M−15%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 5 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | $2.30T+21% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $1.90T−3% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $1.96T+2% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $1.92T+8% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $1.77T+13% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $1.57T−7% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $1.68T+2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $1.64T+5% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $1.56T+5% | SEC ↗ |
| Q1 2024 | May 13, 2024 | $1.49T+14% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $1.30T+13% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $1.16T−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $1.19T−45% | SEC ↗ |
| Q1 2023 | May 11, 2023 (amended) | $2.19T+117% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $1.01T+5% | SEC ↗ |
| Q3 2022 | Nov 10, 2022 | $958.93B−4% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $1.00T−20% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $1.25T−8% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $1.35T+7% | SEC ↗ |
| Q3 2021 | Feb 14, 2022 (amended) | $1.26T−1% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $1.28T+9% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $1.17T+4% | SEC ↗ |
| Q4 2020 | Feb 8, 2021 | $1.12T+14% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $989.33B+9% | SEC ↗ |
| Q2 2020 | Aug 24, 2020 (amended) | $909.48B+26% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $722.13B−20% | SEC ↗ |
| Q4 2019 | Feb 7, 2020 | $906.40B+9% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $833.77B−3% | SEC ↗ |
| Q2 2019 | Aug 13, 2019 | $856.19B+3% | SEC ↗ |
| Q1 2019 | May 13, 2019 (amended) | $834.93B+14% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 (amended) | $730.25B−18% | SEC ↗ |
| Q3 2018 | Nov 9, 2018 | $888.88B+2% | SEC ↗ |
| Q2 2018 | Aug 10, 2018 (amended) | $868.68B+3% | SEC ↗ |
| Q1 2018 | May 14, 2018 | $842.35B−1% | SEC ↗ |
| Q4 2017 | Feb 12, 2018 | $853.06B+3% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $827.12B+3% | SEC ↗ |
| Q2 2017 | Aug 29, 2017 (amended) | $804.55B+2% | SEC ↗ |
| Q1 2017 | May 11, 2017 | $787.10B+5% | SEC ↗ |
| Q4 2016 | Feb 10, 2017 (amended) | $748.25B−0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $750.86B+2% | SEC ↗ |
| Q2 2016 | Aug 11, 2016 | $732.58B+1% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $722.80B | SEC ↗ |